These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 870162

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Comparison of two non-cross-resistant combinations (ABVP/LOPP) with COPP plus bleomycin in the treatment of advanced Hodgkin's disease.
    Koza I, Bohunický L, Mociková K, Gyárfás J, Svancárová L, Mardiak J, Spánik S, Fuchsberger P, Thalmeinerová Z, Sufliarsky J.
    Neoplasma; 1991; 38(6):583-93. PubMed ID: 1722564
    [Abstract] [Full Text] [Related]

  • 27. MOPP/ABV/CAD chemotherapy with and without recombinant human granulocyte-macrophage colony stimulating factor in untreated, unfavorable prognosis Hodgkin's disease.
    Riccardi A, Gobbi P, Danova M, Giordano M, Pieresca C, Bertoloni D, Brugnatelli S, Ascari E.
    Haematologica; 1993; 78(1):44-8. PubMed ID: 7684012
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report.
    Carella AM, Congiu AM, Gaozza E, Mazza P, Ricci P, Visani G, Meloni G, Cimino G, Mangoni L, Coser P.
    J Clin Oncol; 1988 Sep; 6(9):1411-6. PubMed ID: 2458439
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Combination chemotherapy of Hodgkin's disease with vincristine, cyclophosphamide, procarbazine, and prednisolone].
    Aiba K, Ogawa M, Inagaki J, Horikoshi N, Ezaki K, Inoue K, Dohmyo M, Nagata T, Miyamoto H, Kobayashi T, Kuraishi Y.
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):1928-32. PubMed ID: 6897857
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The use of different drugs and combinations in the treatment of Hodgkin's disease.
    Fairley GH.
    Ser Haematol; 1973 Nov; 6(2):196-201. PubMed ID: 4784374
    [No Abstract] [Full Text] [Related]

  • 37. Induction of chromosome breaks and sister chromatid exchanges in patients with Hodgkin's disease by two combination chemotherapy regimens of different leukemogenic potential.
    Sen P, Bailey NM, Hagemeister FB, Liang JC.
    Cancer Res; 1990 Feb 01; 50(3):558-62. PubMed ID: 1688733
    [Abstract] [Full Text] [Related]

  • 38. Eight-drug combination chemotherapy (MOPP and ABDV) and local radiotherapy for advanced Hodgkin's Disease.
    Case DC, Young CW, Nisce L, Lee BJ, Clarkson BD.
    Cancer Treat Rep; 1976 Sep 01; 60(9):1217-23. PubMed ID: 65221
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.